scispace - formally typeset
U

Ulrich Bogdahn

Researcher at University of Regensburg

Publications -  347
Citations -  36060

Ulrich Bogdahn is an academic researcher from University of Regensburg. The author has contributed to research in topics: Neural stem cell & Neurogenesis. The author has an hindex of 67, co-authored 344 publications receiving 32279 citations. Previous affiliations of Ulrich Bogdahn include Hoffmann-La Roche & Volkswagen Foundation.

Papers
More filters
Journal ArticleDOI

Stem cell metabolic and spectroscopic profiling

TL;DR: The findings gained by means of metabolic and spectroscopic profiling methodologies, for example, nuclear magnetic resonance spectroscopy (NMRS), mass spectrometry (MS), and Raman spectroscope (RS), are reviewed, with a focus on neural stem cells and neurogenesis.
Journal ArticleDOI

Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation

TL;DR: The data show that Smad‐dependent and ‐independent intracellular pathways contribute to murine Th17 differentiation and inhibitors of mitogen‐activated protein kinase (MAPK) blocked in vitro polarization of Th17 cells.
Journal ArticleDOI

Intrinsic and extrinsic determinants of central nervous system axon outgrowth into alginate-based anisotropic hydrogels.

TL;DR: It is shown that increasing capillary diameters within such hydrogels enhanced central nervous system axon regeneration at the expense of longitudinal orientation.
Journal ArticleDOI

The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis.

TL;DR: There is an upregulated TGF-β system in specific tissues in ALS that might lead to a “neurotoxic” immune response, promoting disease progression and neurodegeneration, and this system may represent a promising target in treatment of ALS patients.
Journal ArticleDOI

The retrobulbar "spot sign" as a discriminator between vasculitic and thrombo-embolic affections of the retinal blood supply.

TL;DR: The detection of the "spot sign" specifically minimizes the probability of TA as a reason for sudden blindness and excludes vasculitis as a cause.